Veeva Systems (VEEV) 10-Q 4 Jun 20 2021 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Apr. 30, 2020	May 31, 2020
Document And Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2020
Document Transition Report	false
Entity File Number	001-36121
Entity Registrant Name	Veeva Systems Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-8235463
Entity Address, Address Line One	4280 Hacienda Drive
Entity Address, City or Town	Pleasanton
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94588
City Area Code	925
Local Phone Number	452-6500
Title of 12(b) Security	Class A Common Stock,par value $0.00001 per share
Trading Symbol	VEEV
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001393052
Current Fiscal Year End Date	--01-31
Class A common stock
Document And Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		134,987,963
Class B common stock
Document And Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		15,158,728

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Current assets:
Cash and cash equivalents	$ 720,776	$ 476,733
Short-term investments	660,199	610,015
Accounts receivable, net of allowance for doubtful accounts of $192 and $617, respectively	235,923	389,690
Unbilled accounts receivable	37,269	32,817
Prepaid expenses and other current assets	21,105	21,869
Total current assets	1,675,272	1,531,124
Property and equipment, net	52,886	54,752
Deferred costs, net	34,176	35,585
Lease right-of-use-assets	46,923	49,132
Goodwill	438,529	438,529
Intangible assets, net	129,403	134,601
Deferred income taxes, noncurrent	11,701	11,870
Other long-term assets	15,729	16,184
Total assets	2,404,619	2,271,777
Current liabilities:
Accounts payable	15,041	19,420
Accrued compensation and benefits	27,064	25,619
Accrued expenses and other current liabilities	23,405	21,620
Income tax payable	4,441	5,613
Deferred revenue	470,262	468,887
Lease liabilities	10,127	10,013
Total current liabilities	550,340	551,172
Deferred income taxes, noncurrent	1,673	2,417
Lease liabilities, noncurrent	42,430	44,815
Other long-term liabilities	9,140	7,779
Total liabilities	603,583	606,183
Commitments and contingencies
Stockholders’ equity:
Additional paid-in capital	792,660	745,475
Accumulated other comprehensive income	2,146	460
Retained earnings	1,006,228	919,658
Total stockholders’ equity	1,801,036	1,665,594
Total liabilities and stockholders’ equity	2,404,619	2,271,777
Class A common stock
Stockholders’ equity:
Common stock	2	1
Class B common stock
Stockholders’ equity:
Common stock	$ 0	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Allowance for doubtful accounts	$ 192	$ 617
Class A common stock
Common stock, par value (in usd per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	800,000,000	800,000,000
Common stock, shares issued (in shares)	134,844,536	133,892,725
Common stock, shares outstanding (in shares)	134,844,536	133,892,725
Class B common stock
Common stock, par value (in usd per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	190,000,000	190,000,000
Common stock, shares issued (in shares)	15,185,511	15,202,858
Common stock, shares outstanding (in shares)	15,185,511	15,202,858

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Apr. 30, 2020	Apr. 30, 2019
Revenues:
Total revenues		$ 337,106	$ 244,752
Cost of revenues:
Total cost of revenues	[1]	94,880	65,503
Gross profit		242,226	179,249
Operating expenses:
Research and development	[1]	62,237	44,973
Sales and marketing	[1]	55,755	39,617
General and administrative	[1]	36,669	23,490
Total operating expenses	[1]	154,661	108,080
Operating income		87,565	71,169
Other income, net		3,414	6,161
Income before income taxes		90,979	77,330
Provision for income taxes		4,409	3,881
Net income		86,570	73,449
Net income, basic and diluted		$ 86,570	$ 73,449
Net income per share:
Basic (in usd per share)		$ 0.58	$ 0.50
Diluted (in usd per share)		$ 0.54	$ 0.47
Weighted-average shares used to compute net income per share:
Basic (in shares)		149,541	146,708
Diluted (in shares)		159,474	157,910
Other comprehensive income:
Net change in unrealized gain on available-for-sale investments		$ 1,297	$ 962
Net change in cumulative foreign currency translation loss		389	(702)
Comprehensive income		88,256	73,709
Subscription services
Revenues:
Total revenues		270,235	198,115
Cost of revenues:
Total cost of revenues	[1]	43,212	30,378
Professional services and other
Revenues:
Total revenues		66,871	46,637
Cost of revenues:
Total cost of revenues	[1]	$ 51,668	$ 35,125
[1]	Includes stock-based compensation as follows: Cost of revenues: Cost of subscription services $ 1,019 $ 385 Cost of professional services and other 5,074 2,978 Research and development 11,401 6,325 Sales and marketing 8,192 5,152 General and administrative 11,221 5,916 Total stock-based compensation $ 36,907 $ 20,756

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Total stock-based compensation	$ 36,907	$ 20,756
Cost of subscription services
Total stock-based compensation	1,019	385
Cost of professional services and other
Total stock-based compensation	5,074	2,978
Research and development
Total stock-based compensation	11,401	6,325
Sales and marketing
Total stock-based compensation	8,192	5,152
General and administrative
Total stock-based compensation	$ 11,221	$ 5,916

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Class A & B common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive income
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect adjustment for Topic 842 adoption	[1]	$ (657)			$ (657)
Beginning balance at Jan. 31, 2019		1,237,749	$ 1	$ 617,623	619,197	$ 928
Beginning balance (in shares) at Jan. 31, 2019			146,190,079
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			526,054
Issuance of common stock upon exercise of stock options		3,439		3,439
Issuance of common stock upon vesting of restricted stock units (in shares)			314,331
Stock-based compensation expense		20,863		20,863
Other comprehensive income		260				260
Net income		73,449			73,449
Ending balance at Apr. 30, 2019		1,335,103	$ 1	641,925	691,989	1,188
Ending balance (in shares) at Apr. 30, 2019			147,030,464
Beginning balance at Jan. 31, 2020		$ 1,665,594	$ 1	745,475	919,658	460
Beginning balance (in shares) at Jan. 31, 2020			149,095,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		645,515	645,515
Issuance of common stock upon exercise of stock options		$ 10,279	$ 1	10,278
Issuance of common stock upon vesting of restricted stock units (in shares)			288,949
Stock-based compensation expense		36,907		36,907
Other comprehensive income		1,686				1,686
Net income		86,570			86,570
Ending balance at Apr. 30, 2020		$ 1,801,036	$ 2	$ 792,660	$ 1,006,228	$ 2,146
Ending balance (in shares) at Apr. 30, 2020			150,030,047
[1]	We adopted ASU 2016-02, “Leases” (Topic 842) using the modified retrospective method as of February 1, 2019 and elected the transition option that allows us not to restate the comparative periods in our financial statements in the year of adoption.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Cash flows from operating activities
Net income	$ 86,570	$ 73,449
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	7,878	3,900
Reduction of operating lease right-of-use assets	2,997	1,538
Accretion of discount on short-term investments	(11)	(1,178)
Stock-based compensation	36,907	20,756
Amortization of deferred costs	4,751	4,849
Deferred income taxes	(1,134)	418
(Gain) Loss on foreign currency from mark-to-market derivative	93	(80)
Bad debt recovery	(393)	(153)
Changes in operating assets and liabilities:
Accounts receivable	154,160	139,510
Unbilled accounts receivable	(4,452)	(5,244)
Deferred costs	(3,342)	(4,601)
Income taxes payable	(1,850)	338
Prepaid expenses and other current and long-term assets	551	(2,759)
Accounts payable	(4,430)	(416)
Accrued expenses and other current liabilities	2,691	(759)
Deferred revenue	1,477	7,914
Operating lease liabilities	(2,811)	(1,629)
Other long-term liabilities	2,520	436
Net cash provided by operating activities	282,172	236,289
Cash flows from investing activities
Purchases of short-term investments	(188,818)	(228,894)
Maturities and sales of short-term investments	140,342	188,965
Property and equipment	267	(1,194)
Capitalized internal-use software development costs	0	(419)
Net cash used in investing activities	(48,209)	(41,542)
Cash flows from financing activities
Reduction of lease liabilities - finance leases	(248)	(249)
Proceeds from exercise of common stock options	9,781	3,391
Net cash provided by financing activities	9,533	3,142
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	548	(702)
Net change in cash, cash equivalents, and restricted cash	244,044	197,187
Cash, cash equivalents, and restricted cash at beginning of period	479,797	552,178
Cash, cash equivalents, and restricted cash at end of period	723,841	749,365
Cash, cash equivalents, and restricted cash at end of period:
Cash, cash equivalents, and restricted cash at end of period	723,841	749,365
Supplemental disclosures of other cash flow information:
Cash paid for income taxes, net of refunds	5,866	2,383
Excess tax benefits from employee stock plans	19,615	13,552
Non-cash investing and financing activities:
Changes in accounts payable and accrued expenses related to property and equipment purchases	$ 590	$ (634)

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	3 Months Ended
	Apr. 30, 2020
Accounting Policies [Abstract]
Summary of Business and Significant Accounting Policies	Summary of Business and Significant Accounting Policies Description of Business Veeva is the leading provider of industry cloud solutions for the global life sciences industry. We were founded in 2007 on the premise that industry-specific cloud solutions could best address the operating challenges and regulatory requirements of life sciences companies. Our solutions are designed to meet the unique needs of our customers and their most strategic business functions-from research and development (R&D) to commercialization. Our solutions are designed to help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations. Our commercial solutions help life sciences companies achieve better, more intelligent engagement with healthcare professionals and healthcare organizations across multiple communication channels, and plan and execute more effective media and marketing campaigns. Our R&D solutions for the clinical, regulatory, quality, and safety functions help life sciences companies streamline their end-to-end product development processes to increase operational efficiency and maintain regulatory compliance throughout the product life cycle. We also bring the benefits of our content and data management solutions to a set of customers outside of life sciences in three regulated industries: consumer goods, chemicals, and cosmetics. Our fiscal year end is January 31. Principles of Consolidation and Basis of Presentation These unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting and include the accounts of our wholly-owned subsidiaries after elimination of intercompany accounts and transactions. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2020 , filed on March 30, 2020. Except for the change in certain policies upon adoption of the accounting standards in Fiscal 2021, there have been no changes to our significant accounting policies described in the annual report that have had a material impact on our condensed consolidated financial statements and related notes. The condensed consolidated balance sheet as of January 31, 2020 included herein was derived from the audited financial statements as of that date. These unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly our financial position, results of operations, comprehensive income, and cash flows for the interim periods but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2021 or any other period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the condensed consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to: • the standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations; • the determination of the period of benefit for amortization of deferred costs; and • the fair value of assets acquired and liabilities assumed for business combinations. As future events cannot be determined with precision, actual results could differ significantly from those estimates. Revenue Recognition We derive our revenues primarily from subscription services and professional services. Subscription services revenues consist of fees from customers accessing our cloud-based software solutions and subscription or license fees for our data solutions. Professional services and other revenues consist primarily of fees from implementation services, configuration, data services, training, and managed services related to our solutions. Revenues are recognized when control of these services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those services. We determine revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, we satisfy a performance obligation. Our subscription services agreements are generally non-cancelable during the term, although customers typically have the right to terminate their agreements for cause in the event of material breach. Subscription Services Revenues Subscription services revenues are recognized ratably over the respective non-cancelable subscription term because of the continuous transfer of control to the customer. Our subscription arrangements are considered service contracts, and the customer does not have the right to take possession of the software. Professional Services and Other Revenues The majority of our professional services arrangements are billed on a time and materials basis and revenues are recognized over time based on time incurred and contractually agreed upon rates. Certain professional services revenues are billed on a fixed fee basis and revenues are typically recognized over time as the services are delivered based on time incurred. Data services and training revenues are generally recognized as the services are performed. Contracts with Multiple Performance Obligations Some of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately when they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. We determine the standalone selling prices based on our overall pricing objectives, taking into consideration market conditions and other factors, including other groupings such as customer type and geography. Unbilled Accounts Receivable Unbilled accounts receivable consists of (i) a receivable primarily for the revenue recognized for professional services performed but not yet billed, which were $21 million and $18 million as of April 30, 2020 and January 31, 2020 , respectively and (ii) a contract asset primarily for revenue recognized from non-cancelable, multi-year orders in which fees increase annually but for which we are not contractually able to invoice until a future period, which were $17 million and $15 million as of April 30, 2020 and January 31, 2020 , respectively. New Accounting Pronouncements Adopted in Fiscal 2021 Cloud Computing Arrangements In August 2018, the FASB issued ASU No. 2018-15, “ Intangibles-Goodwill and Other-Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract ” (Topic 350-40), which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new standard requires capitalized costs to be amortized on a straight-line basis generally over the term of the arrangement, and the financial statement presentation for these capitalized costs would be the same as that of the fees related to the hosting arrangements. We adopted this standard on a prospective basis as of February 1, 2020 and it did not have a material impact on our condensed consolidated financial statements. Credit Losses In June 2016, the Financial Accounting Standards Board, or FASB, issued ASU 2016-13, including subsequent amendments, regarding “ Measurement of Credit Losses on Financial Instruments ” (Topic 326), which modifies the accounting methodology for most financial instruments. The guidance establishes a new “expected loss model” that requires entities to estimate current expected credit losses on financial instruments by using all practical and relevant information. For trade receivables and other financial assets, we are required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Additionally, any expected credit losses are to be reflected as allowances rather than reductions in the amortized cost of available-for-sale debt securities. We adopted this standard on a modified retrospective basis as of February 1, 2020. The adoption of this standard did not result in any cumulative effect adjustment on our condensed consolidated financial statements.

Acquisitions

Acquisitions	3 Months Ended
	Apr. 30, 2020
Business Combinations [Abstract]
Acquisitions	Acquisitions Crossix On November 1, 2019, we acquired 100% ownership of Crossix in exchange for total consideration of $428 million , which includes the impact of adjustments to purchase price associated with the cash and net working capital of the acquired entity at close. In addition, we granted certain Crossix employees equity retention awards valued at approximately $120 million in the aggregate, which will be expensed as share-based compensation over the remaining service period. Crossix brings Veeva additional depth in patient data and data analytics, and we are integrating Crossix with our Veeva CRM and OpenData products. The following unaudited pro forma information presents the combined results of operations for the periods presented as if the acquisition had been completed on February 1, 2019, the beginning of the comparable prior annual reporting period. The unaudited pro forma results include the amortization associated with estimates for the purchased intangible assets and stock-based compensation expense associated with the retention awards granted. The unaudited pro forma results do not reflect any cost saving synergies from operating efficiencies or the effect of the incremental costs incurred in integrating the two companies. Accordingly, these unaudited pro forma results are presented for information purpose only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations (in thousands): Three months ended April 30, 2019 (Unaudited) Pro forma revenues $ 260,351 Pro forma net income $ 67,818 Pro forma net income per share: Basic $ 0.46 Diluted $ 0.43 Physicians World On November 7, 2019, we completed our acquisition of Physicians World in exchange for total cash consideration of $41 million , which includes the impact of adjustments to purchase price associated with the cash and net working capital of the acquired entity at close. In addition, we granted certain Physicians World employees equity retention awards valued at approximately $15 million in the aggregate. Acquiring Physicians World makes it easier for our customers to get industry leading cloud software and services from a single vendor. Pro forma results of operations have not been presented for the three months ended April 30, 2019 because the effect of this acquisition was not material to our condensed consolidated financial statements.

Short-Term Investments

Short-Term Investments	3 Months Ended
	Apr. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Short-Term Investments	Short-Term Investments At April 30, 2020 , short-term investments consisted of the following (in thousands): Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available-for-sale securities: Certificates of deposits $ 11,600 $ 38 $ (55 ) $ 11,583 Asset-backed securities 104,406 476 (162 ) 104,720 Commercial paper 37,028 47 (24 ) 37,051 Corporate notes and bonds 270,889 2,283 (410 ) 272,762 Foreign government bonds 4,803 32 (35 ) 4,800 U.S. agency obligations 4,999 3 — 5,002 U.S. treasury securities 222,201 2,080 — 224,281 Total available-for-sale securities $ 655,926 $ 4,959 $ (686 ) $ 660,199 At January 31, 2020 , short-term investments consisted of the following (in thousands): Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available-for-sale securities: Certificates of deposits $ 3,500 $ 3 $ — $ 3,503 Asset-backed securities 100,419 396 (1 ) 100,814 Commercial paper 19,965 5 (1 ) 19,969 Corporate notes and bonds 234,664 1,552 (2 ) 236,214 Foreign government bonds 3,397 10 — 3,407 U.S. treasury securities 245,509 599 — 246,108 Total available-for-sale securities $ 607,454 $ 2,565 $ (4 ) $ 610,015 The following table summarizes the estimated fair value of our short-term investments, designated as available-for-sale and classified by the contractual maturity date of the securities as of the dates shown (in thousands): April 30, January 31, Due in one year or less $ 282,638 $ 247,592 Due in greater than one year 377,561 362,423 Total $ 660,199 $ 610,015 The following table shows the fair values of these available-for-sale securities, some of which have been in an unrealized loss position for more than 12 months, aggregated by investment category as of April 30, 2020 (in thousands): Fair value Gross unrealized losses Certificates of deposits $ 7,945 $ (55 ) Asset-backed securities 19,765 (162 ) Commercial paper 10,609 (24 ) Corporate notes and bonds 56,364 (410 ) Foreign government bonds 3,545 (35 ) The following table shows the fair values of these available-for-sale securities, some of which have been in an unrealized loss position for more than 12 months , aggregated by investment category as of January 31, 2020 (in thousands): Fair value Gross unrealized losses Asset-backed securities $ 2,623 $ (1 ) Commercial paper 5,589 (1 ) Corporate notes and bonds 9,105 (2 ) We have not recorded an allowance for credit losses, as we believe any such losses would be immaterial based on the the high credit quality of our investments. We intend to hold our securities to maturity and it is unlikely that they would be sold before their cost bases are recovered.

Deferred Costs

Deferred Costs	3 Months Ended
	Apr. 30, 2020
Deferred Costs [Abstract]
Deferred Costs	Deferred Costs Deferred costs, which consist primarily of deferred sales commissions, were $34 million and $36 million as of April 30, 2020 and January 31, 2020 , respectively. Amortization expense for the deferred costs included in sales and marketing expenses in the condensed consolidated statements of comprehensive income was $5 million for both the three months ended April 30, 2020 and 2019 . There have been no impairment losses recorded in relation to the costs capitalized for any period presented.

Property and Equipment, Net

Property and Equipment, Net	3 Months Ended
	Apr. 30, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net consists of the following as of the dates shown (in thousands): April 30, January 31, Land $ 3,040 $ 3,040 Building 20,984 20,984 Land improvements and building improvements 22,392 22,392 Equipment and computers 10,871 11,066 Furniture and fixtures 12,807 12,849 Leasehold improvements 9,369 9,385 Construction in progress 645 386 80,108 80,102 Less accumulated depreciation (27,222 ) (25,350 ) Total property and equipment, net $ 52,886 $ 54,752 Total depreciation expense was $2 million for both the three months ended April 30, 2020 and 2019 . Land is not depreciated.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Apr. 30, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Goodwill and Intangible Assets	Intangible Assets Goodwill as of April 30, 2020 and January 31, 2020 was $439 million for both periods presented. The following schedule presents the details of intangible assets as of April 30, 2020 (dollar amounts in thousands): April 30, 2020 Gross carrying amount Accumulated amortization Net Remaining useful life (in years) Existing technology $ 26,380 $ (5,737 ) 20,643 5.5 Customer relationships 111,443 (20,272 ) 91,171 8.7 Trade name/Trademarks 13,900 (1,426 ) 12,474 4.4 Other intangibles 22,947 (17,832 ) 5,115 5.3 $ 174,670 $ (45,267 ) 129,403 The following schedule presents the details of intangible assets as of January 31, 2020 (dollar amounts in thousands): January 31, 2020 Gross carrying amount Accumulated amortization Net Remaining useful life (in years) Existing technology $ 26,380 $ (4,808 ) 21,572 5.8 Customer relationships 111,443 (17,575 ) 93,868 9.0 Trade name/Trademarks 13,900 (720 ) 13,180 4.7 Other intangibles 22,947 (16,966 ) 5,981 5.0 $ 174,670 $ (40,069 ) 134,601 Amortization expense associated with intangible assets was $5 million and $2 million for the three months ended April 30, 2020 and 2019 , respectively. As of April 30, 2020 , the estimated amortization expense for intangible assets, for the next five years and thereafter is as follows (in thousands): Period Estimated amortization expense Remaining for Fiscal 2021 $ 14,396 Fiscal 2022 18,397 Fiscal 2023 18,342 Fiscal 2024 18,160 Fiscal 2025 17,417 Thereafter 42,691 Total $ 129,403

Accrued Expenses

Accrued Expenses	3 Months Ended
	Apr. 30, 2020
Payables and Accruals [Abstract]
Accrued Expenses	Accrued Expenses Accrued expenses consisted of the following as of the dates shown (in thousands): April 30, January 31, Accrued commissions $ 5,868 $ 8,951 Accrued bonus 3,853 4,329 Accrued vacation 4,960 3,921 Payroll tax payable 10,236 7,353 Accrued other compensation and benefits 2,147 1,065 Total accrued compensation and benefits $ 27,064 $ 25,619 Accrued fees payable to salesforce.com 6,059 5,787 Marketing event accruals 3,945 1,132 Taxes payable 3,452 4,914 Accrued third-party professional services subcontractors' fees 1,429 1,338 Other accrued expenses 8,520 8,449 Total accrued expenses and other current liabilities $ 23,405 $ 21,620

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Apr. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The carrying amounts of accounts receivable and other current assets, accounts payable and accrued liabilities approximate their fair value due to their short-term nature. Financial assets and liabilities recorded at fair value in the condensed consolidated financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels, which are directly related to the amount of subjectivity associated with the inputs to the valuation of these assets or liabilities are as follows: Level 1—Observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Financial assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires management to make judgments and considers factors specific to the asset or liability. The following table presents the fair value hierarchy for financial assets measured at fair value on a recurring basis as of April 30, 2020 (in thousands): Level 1 Level 2 Total Assets Cash equivalents: Money market funds $ 307,042 $ — $ 307,042 Certificates of deposits — 150,000 150,000 Commercial paper — 7,496 7,496 Corporate notes and bonds — 2,229 2,229 Short-term investments: Certificates of deposits — 11,583 11,583 Asset-backed securities — 104,720 104,720 Commercial paper — 37,051 37,051 Corporate notes and bonds — 272,761 272,761 Foreign government bonds — 4,800 4,800 U.S. agency obligations — 5,002 5,002 U.S. treasury securities — 224,281 224,281 Foreign currency derivative contracts — 13 13 Total $ 307,042 $ 819,936 $ 1,126,978 Liabilities Foreign currency derivative contracts — 74 74 Total $ — $ 74 $ 74 The following table presents the fair value hierarchy for financial assets measured at fair value on a recurring basis as of January 31, 2020 (in thousands): Level 1 Level 2 Total Assets Cash equivalents: Money market funds $ 24,107 $ — $ 24,107 Commercial paper — 1,616 1,616 Corporate notes and bonds — 2,245 2,245 Short-term investments: Certificates of deposits — 3,503 3,503 Asset-backed securities — 100,815 100,815 Commercial paper — 19,969 19,969 Corporate notes and bonds — 236,214 236,214 Foreign government bonds — 3,407 3,407 U.S. treasury securities — 246,107 246,107 Foreign currency derivative contracts — 75 75 Total $ 24,107 $ 613,951 $ 638,058 Liabilities Foreign currency derivative contracts — 42 42 Total $ — $ 42 $ 42 We determine the fair value of our security holdings based on pricing from our service providers and market prices from industry-standard independent data providers. The valuation techniques used to measure the fair value of financial instruments having Level 2 inputs were derived from non-binding consensus prices that are corroborated by observable market data or quoted market prices for similar instruments. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs). The carrying amounts of accounts receivable and other current assets, accounts payable and accrued liabilities approximate their fair value due to their short-term nature. Balance Sheet Hedges We enter into foreign currency forward contracts (the “Forward Contracts”) in order to hedge our foreign currency exposure. We account for derivative instruments at fair value with changes in the fair value recorded as a component of other income, net in our condensed consolidated statements of comprehensive income. Cash flows from such forward contracts are classified as operating activities. The realized foreign currency gains we recognized for both the three months ended April 30, 2020 and 2019 was immaterial . The fair value of our outstanding derivative instruments is summarized below (in thousands): April 30, January 31, Notional amount of foreign currency derivative contracts $ 10,005 $ 7,304 Fair value of foreign currency derivative contracts 10,065 7,271 Details on outstanding balance sheet hedges are presented below as of the date shown below (in thousands): Derivatives not designated as hedging instruments Balance sheet location April 30, January 31, Derivative Assets Foreign currency derivative contracts Prepaid expenses and other current assets $ 13 $ 75 Derivative Liabilities Foreign currency derivative contracts Accrued expenses $ 74 $ 42

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three months ended April 30, 2020 and 2019 , our effective tax rates were 4.8% and 5.0% , respectively. During the three months ended April 30, 2020 as compared to the prior year period, our effective tax rate decreased primarily due to the increase in excess tax benefits related to equity compensation, partially offset by reduced tax credits. We recognized such excess tax benefits in our provision for income taxes of $20 million and $14 million for the three months ended April 30, 2020 and 2019 , respectively.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	3 Months Ended
	Apr. 30, 2020
Revenue Recognition and Deferred Revenue [Abstract]
Deferred Revenue and Performance Obligations	Deferred Revenue and Performance Obligations Of the beginning deferred revenue balance for the respective periods, we recognized $192 million and $146 million of subscription services revenue during the three months ended April 30, 2020 and 2019 , respectively. Professional services revenue recognized in the same periods from deferred revenue balances at the beginning of the respective periods was immaterial. Transaction Price Allocated to the Remaining Performance Obligations Transaction price allocated to the remaining performance obligations represents contracted revenue that has not yet been recognized, which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized as revenues in future periods. We applied the practical expedient in accordance with ASU 2014-09, “ Revenue from Contracts with Customers ” (Topic 606) to exclude the amounts related to professional services contracts as these contracts generally have a remaining duration of one year or less. Revenue from remaining performance obligations for professional services contracts as of April 30, 2020 was immaterial. As of April 30, 2020 , approximately $913 million of revenue is expected to be recognized from remaining performance obligations for subscription services contracts. We expect to recognize revenue on approximately 79% of these remaining performance obligations over the next 12 months , with the balance recognized thereafter.

Leases

Leases	3 Months Ended
	Apr. 30, 2020
Leases [Abstract]
Leases	Leases We have operating and finance leases for corporate offices, data centers, and certain equipment. Our leases have various expiration dates through 2030, some of which include options to extend the leases for up to nine years . Additionally, we are the sublessor for certain office space. Our sublease income for the three months ended April 30, 2020 was immaterial. We did not have any sublease income for the three months ended April 30, 2019 . For the three months ended April 30, 2020 and 2019 , our operating lease expense was $3 million and $2 million , respectively. Our finance lease expense was immaterial for both the three months ended April 30, 2020 and 2019 . Supplemental cash flow information related to leases was as follows (in thousands): Three months ended April 30, 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 2,563 $ 1,507 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 306 $ 941 Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount rate): As of As of Operating Leases Lease right-of-use-assets $ 46,923 $ 49,132 Lease liabilities $ 9,114 $ 8,960 Lease liabilities, noncurrent 42,344 44,453 Total operating lease liabilities $ 51,458 $ 53,413 Finance Leases Property and equipment, at cost $ 1,674 $ 1,761 Accumulated depreciation (1,569 ) (1,320 ) Property and equipment, net $ 105 $ 441 Lease liabilities $ 1,013 $ 1,054 Lease liabilities, noncurrent 86 362 Total finance lease liabilities $ 1,099 $ 1,416 Weighted Average Remaining Lease Term Operating leases 7.0 years 7.1 years Finance leases 1.1 years 1.3 years Weighted Average Discount Rate Operating leases 4.2 % 4.3 % Finance leases 4.3 % 4.3 % As of April 30, 2020 , remaining maturities of lease liabilities are as follows (in thousands): Period Operating leases Finance leases Remaining for Fiscal 2021 $ 8,150 $ 778 Fiscal 2022 10,233 346 Fiscal 2023 8,102 — Fiscal 2024 7,352 — Fiscal 2025 5,338 — Thereafter 20,822 — Total lease payments 59,997 1,124 Less imputed interest (8,539 ) (25 ) Total $ 51,458 $ 1,099 As of April 30, 2020 , we have additional operating leases, primarily for office leases, that have not yet commenced of $3 million . These operating leases will commence during the fiscal year ending January 31, 2021 with lease terms of three to five years .
Leases	Leases We have operating and finance leases for corporate offices, data centers, and certain equipment. Our leases have various expiration dates through 2030, some of which include options to extend the leases for up to nine years . Additionally, we are the sublessor for certain office space. Our sublease income for the three months ended April 30, 2020 was immaterial. We did not have any sublease income for the three months ended April 30, 2019 . For the three months ended April 30, 2020 and 2019 , our operating lease expense was $3 million and $2 million , respectively. Our finance lease expense was immaterial for both the three months ended April 30, 2020 and 2019 . Supplemental cash flow information related to leases was as follows (in thousands): Three months ended April 30, 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 2,563 $ 1,507 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 306 $ 941 Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount rate): As of As of Operating Leases Lease right-of-use-assets $ 46,923 $ 49,132 Lease liabilities $ 9,114 $ 8,960 Lease liabilities, noncurrent 42,344 44,453 Total operating lease liabilities $ 51,458 $ 53,413 Finance Leases Property and equipment, at cost $ 1,674 $ 1,761 Accumulated depreciation (1,569 ) (1,320 ) Property and equipment, net $ 105 $ 441 Lease liabilities $ 1,013 $ 1,054 Lease liabilities, noncurrent 86 362 Total finance lease liabilities $ 1,099 $ 1,416 Weighted Average Remaining Lease Term Operating leases 7.0 years 7.1 years Finance leases 1.1 years 1.3 years Weighted Average Discount Rate Operating leases 4.2 % 4.3 % Finance leases 4.3 % 4.3 % As of April 30, 2020 , remaining maturities of lease liabilities are as follows (in thousands): Period Operating leases Finance leases Remaining for Fiscal 2021 $ 8,150 $ 778 Fiscal 2022 10,233 346 Fiscal 2023 8,102 — Fiscal 2024 7,352 — Fiscal 2025 5,338 — Thereafter 20,822 — Total lease payments 59,997 1,124 Less imputed interest (8,539 ) (25 ) Total $ 51,458 $ 1,099 As of April 30, 2020 , we have additional operating leases, primarily for office leases, that have not yet commenced of $3 million . These operating leases will commence during the fiscal year ending January 31, 2021 with lease terms of three to five years .

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Apr. 30, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stockholders' Equity	Stockholders’ Equity Stock Option Activity A summary of stock option activity for the three months ended April 30, 2020 is as follows: Number of shares Weighted average exercise price Weighted average remaining contractual term (in years) Aggregate intrinsic value Options outstanding at January 31, 2020 13,448,026 $ 40.64 5.4 $ 1,426,502,005 Options granted 1,264,192 172.55 Options exercised (645,515 ) 15.92 Options forfeited/cancelled (44,252 ) 84.44 Options outstanding at April 30, 2020 14,022,451 $ 53.40 5.6 $ 1,926,725,769 Options vested and exercisable at April 30, 2020 6,759,113 $ 11.99 3.3 $ 1,208,620,921 Options vested and exercisable at April 30, 2020 and 14,022,451 $ 53.40 5.6 $ 1,926,725,769 The options granted during the three months ended April 30, 2020 reflects grants predominantly made in connection with our annual performance review cycle. The weighted average grant-date fair value of options granted was $68.56 for the three months ended April 30, 2020 . As of April 30, 2020 , there was $265 million in unrecognized compensation cost related to unvested stock options granted under the 2012 Equity Incentive Plan and 2013 Equity Incentive Plan (2013 EIP). This cost is expected to be recognized over a weighted average period of 3.8 years . As of April 30, 2020 , we had authorized and unissued shares of common stock sufficient to satisfy exercises of stock options. The total intrinsic value of options exercised was approximately $90 million for the three months ended April 30, 2020 . Restricted Stock Units A summary of restricted stock unit (RSU) activity for the three months ended April 30, 2020 is as follows: Unreleased restricted stock units Weighted average grant date fair value Balance at January 31, 2020 1,818,622 $ 95.23 RSUs granted 373,055 171.58 RSUs vested (289,471 ) 75.03 RSUs forfeited/cancelled (29,608 ) 74.92 Balance at April 30, 2020 1,872,598 $ 113.90 As of April 30, 2020 , there was a total of $196 million in unrecognized compensation cost related to unvested RSUs. This cost is expected to be recognized over a weighted-average period of approximately 2.5 years . The total intrinsic value of RSUs vested was $43 million for the three months ended April 30, 2020 . Stock-Based Compensation The following table presents the weighted-average assumptions used to estimate the grant date fair value of options granted during the periods presented: Three months ended 2020 2019 Volatility 39% - 41% 41% Expected term (in years) 6.25 - 7.25 5.75 - 6.35 Risk-free interest rate 0.51% - 1.43% 2.36% - 2.52% Dividend yield —% —%

Net Income per Share

Net Income per Share	3 Months Ended
	Apr. 30, 2020
Earnings Per Share [Abstract]
Net Income per Share	Net Income per Share Basic net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing net income by the weighted-average shares outstanding, including potentially dilutive shares of common equivalents outstanding during the period. The dilutive effect of potential shares of common stock are determined using the treasury stock method. The computation of fully diluted net income per share of Class A common stock assumes the conversion from Class B common stock, while the fully diluted net income per share of Class B common stock does not assume the conversion of those shares. The numerators and denominators of the basic and diluted EPS computations for our common stock are calculated as follows (in thousands, except per share data): Three months ended April 30, 2020 2019 Class A Class B Class A Class B Basic Numerator Net income, basic $ 77,777 $ 8,793 $ 63,652 $ 9,797 Denominator Weighted average shares used in computing net income per share, basic 134,353 15,188 127,139 19,569 Net income per share, basic $ 0.58 $ 0.58 $ 0.50 $ 0.50 Diluted Numerator Net income, basic $ 77,777 $ 8,793 $ 63,652 $ 9,797 Reallocation as a result of conversion of Class B to Class A common stock: Net income, basic 8,793 — 9,797 — Reallocation of net income to Class B common stock — 4,844 — 4,516 Net income, diluted $ 86,570 $ 13,637 $ 73,449 $ 14,313 Denominator Number of shares used for basic EPS computation 134,353 15,188 127,139 19,569 Conversion of Class B to Class A common stock 15,188 — 19,569 — Effect of potentially dilutive common shares 9,933 9,933 11,202 11,202 Weighted average shares used in computing net income per share, diluted 159,474 25,121 157,910 30,771 Net income per share, diluted $ 0.54 $ 0.54 $ 0.47 $ 0.47 Potential common share equivalents excluded where the inclusion would be anti-dilutive are as follows: Three months ended 2020 2019 Options and awards to purchase shares not included in the computation of diluted net income per share because their inclusion would be anti-dilutive 2,386,498 376,944

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation IQVIA Litigation Matters. Veeva OpenData and Veeva Network Action. On January 10, 2017 , IQVIA Inc. (formerly Quintiles IMS Incorporated) and IMS Software Services, Ltd. (collectively, “IQVIA”) filed a complaint against us in the U.S. District Court for the District of New Jersey (IQVIA Inc. v. Veeva Systems Inc. (No. 2:17-cv-00177)) (“OpenData and Network Action”). In the complaint, IQVIA alleges that we have used unauthorized access to proprietary IQVIA data to improve our software and data products and that our software is designed to steal IQVIA trade secrets. IQVIA further alleges that we have intentionally gained unauthorized access to IQVIA proprietary information to gain an unfair advantage in marketing our products and that we have made false statements concerning IQVIA’s conduct and our data security capabilities. IQVIA asserts claims under both federal and state misappropriation of trade secret laws, federal false advertising law, and common law claims for unjust enrichment, tortious interference, and unfair trade practices. The complaint seeks declaratory and injunctive relief and unspecified monetary damages. On March 13, 2017, we filed our answer and counterclaims in the OpenData and Network Action. Our counterclaims allege that IQVIA has abused monopoly power as the dominant provider of data products for life sciences companies to exclude Veeva OpenData and Veeva Network from their respective markets. The counterclaims allege that IQVIA has engaged in various tactics to prevent customers from using our applications and has deliberately raised costs and difficulty for customers attempting to switch from IQVIA to our data products. As amended, our counterclaims assert federal and state antitrust claims, as well as claims under California’s Unfair Practices Act and common law claims for intentional interference with contractual relations, intentional interference with prospective economic advantage, and negligent misrepresentation. The counterclaims seek injunctive relief, monetary damages exceeding $200 million , and attorneys’ fees. On May 3, 2017, in lieu of filing an answer, IQVIA filed a motion to dismiss our counterclaims. On October 3, 2018, the court denied IQVIA’s motion to dismiss and allowed our antitrust claims to proceed. In addition, on December 3, 2018, we filed an amended answer and counterclaims. IQVIA filed its answer and affirmative defenses on December 21, 2018. On February 18, 2020, IQVIA filed a motion for sanctions against Veeva, seeking default judgment and dismissal and, in the alternative, a negative inference at trial. Veeva responded to the motion on May 14, 2020. The court has referred the motion to the Special Master appointed to assist the court with discovery and pretrial disputes. Discovery is currently in process. While it is not possible at this time to predict with any degree of certainty the ultimate outcome of this action, and we are unable to make a meaningful estimate of the amount or range of gain or loss, if any, that could result from the OpenData and Network Action, we believe that IQVIA’s claims lack merit and that our counterclaims warrant injunctive relief and monetary damages for Veeva. Veeva Nitro Action. On July 17, 2019, IQVIA filed a lawsuit in the U.S. District Court for the District of New Jersey (IQVIA Inc. v. Veeva Systems Inc. (No. 2:19-cv-15517)) (“IQVIA Declaratory Action”) seeking a declaratory judgment that IQVIA is not liable to Veeva for disallowing use of IQVIA’s data products in Veeva Nitro or any later-introduced Veeva SaaS products. The IQVIA Declaratory Action does not seek any monetary relief. On July 18, 2019, we filed a lawsuit against IQVIA in the U.S. District Court for the Northern District of California (Veeva Systems Inc. v. IQVIA Inc. (No. 3:19-cv-04137)) (“Veeva Nitro Action”), alleging that IQVIA engaged in anticompetitive conduct as to Veeva Nitro. Our complaint asserts federal and state antitrust claims, as well as claims under California’s Unfair Competition Law and common law claims for intentional interference with contractual relations and intentional interference with prospective economic advantage. The complaint seeks injunctive relief and monetary damages. IQVIA filed its answer and affirmative defenses on September 5, 2019. On September 26, 2019, the Northern District of California transferred the Veeva Nitro Action to the U.S. District Court for the District of New Jersey. On March 24, 2020, we amended our complaint in the Veeva Nitro Action to include allegations of IQVIA’s anticompetitive conduct as to additional Veeva software applications, such as Veeva Andi, Veeva Align, and Veeva Vault MedComms; additional examples of IQVIA’s monopolistic behavior against Veeva Nitro; IQVIA’s unlawful access of Veeva’s proprietary software products; and a request for declaratory relief. IQVIA answered the amended complaint on May 22, 2020. The parties have consented to consolidation of the IQVIA Declaratory Action and the Veeva Nitro Action. The court has not yet entered an order consolidating the two actions. There are no motions currently pending in the IQVIA Declaratory Action or the Veeva Nitro Action that have the potential to end the cases. The court has not yet held a scheduling conference to set the case management schedule. While it is not possible at this time to predict with any degree of certainty the ultimate outcome of these two actions, we believe that our claims warrant injunctive and declaratory relief and monetary damages for Veeva and against IQVIA. Medidata Litigation Matter. On January 26, 2017 , Medidata Solutions, Inc. filed a complaint in the U.S. District Court for the Southern District of New York ( Medidata Solutions, Inc. v. Veeva Systems Inc. et al. (No. 1:17-cv-00589)) against us and five individual Veeva employees who previously worked for Medidata (“Individual Employees”). The complaint alleged that we induced and conspired with the Individual Employees to breach their employment agreements, including non-compete and confidentiality provisions, and to misappropriate Medidata’s confidential and trade secret information. The complaint sought declaratory and injunctive relief, unspecified monetary damages, and attorneys’ fees. Medidata has since amended its complaint twice, asserting the same claims with additional factual allegations, and has voluntarily dismissed the Individual Defendants without prejudice. Discovery is now completed. On April 24, 2020, Medidata filed a motion for partial summary judgment on its claims for trade secret misappropriation as well as several of Veeva’s affirmative defenses. On May 15, 2020, we filed a motion for summary judgment on all of Medidata’s claims. Briefing on the parties’ cross-motions will be completed by June 17, 2020. No trial date has been set. While it is not possible at this time to predict with any degree of certainty the ultimate outcome of this action, and we are unable to make a meaningful estimate of the amount or range of loss, if any, that could result from any unfavorable outcome, we believe that Medidata’s claims lack merit. Other Litigation Matters From time to time, we may be involved in other legal proceedings and subject to claims incident to the ordinary course of business. Although the results of such legal proceedings and claims cannot be predicted with certainty, we believe we are not currently a party to any other legal proceedings, the outcome of which, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows or financial position. Regardless of the outcome, such proceedings can have an adverse impact on us because of defense and settlement costs, diversion of resources and other factors, and there can be no assurances that favorable outcomes will be obtained. Value-Added Reseller Agreement We have a value-added reseller agreement with salesforce.com, inc. for our use of the Salesforce1 Platform in combination with our developed technology to deliver certain of our multichannel CRM applications, including hosting infrastructure and data center operations provided by salesforce.com. The agreement, as amended, requires that we meet minimum order commitments of $500 million over the term of the agreement, which ends on September 1, 2025, including “true-up” payments if the orders we place with salesforce.com have not equaled or exceeded the following aggregate amounts within the timeframes indicated: (i) $250 million for the period from March 1, 2014 to September 1, 2020 and (ii) the full amount of $500 million by September 1, 2025 . We have met our first minimum order requirement commitment of $250 million , and as of April 30, 2020 , we remained obligated to pay fees of at least $120 million prior to September 1, 2025 in connection with this agreement.

Revenues by Product

Revenues by Product	3 Months Ended
	Apr. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenues by Product	Revenues by Product Our industry cloud solutions are grouped into two key product areas—Veeva Commercial Cloud and Veeva Vault. Veeva Commercial Cloud is a suite of multichannel CRM applications, territory allocation and alignment applications, master data management applications, customer reference and key opinion leader data, data analytics, and other related services. Veeva Vault is a unified suite of cloud-based, enterprise content and data management applications. Total revenues consist of the following (in thousands): Three months ended 2020 2019 Subscription services Veeva Commercial Cloud $ 142,577 $ 105,796 Veeva Vault 127,658 92,319 Total subscription services $ 270,235 $ 198,115 Professional services Veeva Commercial Cloud $ 27,376 $ 17,221 Veeva Vault 39,495 29,416 Total professional services $ 66,871 $ 46,637 Total revenues $ 337,106 $ 244,752

Information about Geographic Ar

Information about Geographic Areas	3 Months Ended
	Apr. 30, 2020
Segment Reporting [Abstract]
Information about Geographic Areas	Information about Geographic Areas We track and allocate revenues by principal geographic area rather than by individual country, which makes it impractical to disclose revenues for the United States or other specific foreign countries. We measure subscription services revenue primarily by the estimated location of the end users in each geographic area for Veeva Commercial Cloud and primarily by the estimated location of usage in each geographic area for Veeva Vault. We measure professional services revenue primarily by the location of the resources performing the professional services. Total revenues by geographic area were as follows for the periods shown below (in thousands): Three months ended April 30, 2020 2019 Revenues by geography North America $ 195,657 $ 132,131 Europe 89,422 70,374 Asia Pacific 42,292 34,368 Rest of world (1) 9,735 7,879 Total revenues $ 337,106 $ 244,752 _________________________________________________________ (1) Middle East, Africa, and Latin America Long-lived assets by geographic area are as follows as of the periods shown below (in thousands): April 30, January 31, 2020 2020 Long-lived assets by geography North America $ 46,536 $ 51,334 Europe and rest of world 1,756 2,077 Asia Pacific 4,594 1,341 Total long-lived assets $ 52,886 $ 54,752

Summary of Business and Signi_2

Summary of Business and Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2020
Accounting Policies [Abstract]
Description of Business	Description of Business Veeva is the leading provider of industry cloud solutions for the global life sciences industry. We were founded in 2007 on the premise that industry-specific cloud solutions could best address the operating challenges and regulatory requirements of life sciences companies. Our solutions are designed to meet the unique needs of our customers and their most strategic business functions-from research and development (R&D) to commercialization. Our solutions are designed to help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations. Our commercial solutions help life sciences companies achieve better, more intelligent engagement with healthcare professionals and healthcare organizations across multiple communication channels, and plan and execute more effective media and marketing campaigns. Our R&D solutions for the clinical, regulatory, quality, and safety functions help life sciences companies streamline their end-to-end product development processes to increase operational efficiency and maintain regulatory compliance throughout the product life cycle. We also bring the benefits of our content and data management solutions to a set of customers outside of life sciences in three regulated industries: consumer goods, chemicals, and cosmetics. Our fiscal year end is January 31.
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation These unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting and include the accounts of our wholly-owned subsidiaries after elimination of intercompany accounts and transactions. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2020 , filed on March 30, 2020. Except for the change in certain policies upon adoption of the accounting standards in Fiscal 2021, there have been no changes to our significant accounting policies described in the annual report that have had a material impact on our condensed consolidated financial statements and related notes. The condensed consolidated balance sheet as of January 31, 2020 included herein was derived from the audited financial statements as of that date. These unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly our financial position, results of operations, comprehensive income, and cash flows for the interim periods but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2021 or any other period.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the condensed consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to: • the standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations; • the determination of the period of benefit for amortization of deferred costs; and • the fair value of assets acquired and liabilities assumed for business combinations. As future events cannot be determined with precision, actual results could differ significantly from those estimates.
Revenue Recognition	Revenue Recognition We derive our revenues primarily from subscription services and professional services. Subscription services revenues consist of fees from customers accessing our cloud-based software solutions and subscription or license fees for our data solutions. Professional services and other revenues consist primarily of fees from implementation services, configuration, data services, training, and managed services related to our solutions. Revenues are recognized when control of these services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those services. We determine revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, we satisfy a performance obligation. Our subscription services agreements are generally non-cancelable during the term, although customers typically have the right to terminate their agreements for cause in the event of material breach. Subscription Services Revenues Subscription services revenues are recognized ratably over the respective non-cancelable subscription term because of the continuous transfer of control to the customer. Our subscription arrangements are considered service contracts, and the customer does not have the right to take possession of the software. Professional Services and Other Revenues The majority of our professional services arrangements are billed on a time and materials basis and revenues are recognized over time based on time incurred and contractually agreed upon rates. Certain professional services revenues are billed on a fixed fee basis and revenues are typically recognized over time as the services are delivered based on time incurred. Data services and training revenues are generally recognized as the services are performed. Contracts with Multiple Performance Obligations Some of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately when they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. We determine the standalone selling prices based on our overall pricing objectives, taking into consideration market conditions and other factors, including other groupings such as customer type and geography. Unbilled Accounts Receivable Unbilled accounts receivable consists of (i) a receivable primarily for the revenue recognized for professional services performed but not yet billed, which were $21 million and $18 million as of April 30, 2020 and January 31, 2020
New Accounting Pronouncements Adopted in Fiscal 2021	New Accounting Pronouncements Adopted in Fiscal 2021 Cloud Computing Arrangements In August 2018, the FASB issued ASU No. 2018-15, “ Intangibles-Goodwill and Other-Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract ” (Topic 350-40), which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new standard requires capitalized costs to be amortized on a straight-line basis generally over the term of the arrangement, and the financial statement presentation for these capitalized costs would be the same as that of the fees related to the hosting arrangements. We adopted this standard on a prospective basis as of February 1, 2020 and it did not have a material impact on our condensed consolidated financial statements. Credit Losses In June 2016, the Financial Accounting Standards Board, or FASB, issued ASU 2016-13, including subsequent amendments, regarding “ Measurement of Credit Losses on Financial Instruments ” (Topic 326), which modifies the accounting methodology for most financial instruments. The guidance establishes a new “expected loss model” that requires entities to estimate current expected credit losses on financial instruments by using all practical and relevant information. For trade receivables and other financial assets, we are required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Additionally, any expected credit losses are to be reflected as allowances rather than reductions in the amortized cost of available-for-sale debt securities. We adopted this standard on a modified retrospective basis as of February 1, 2020. The adoption of this standard did not result in any cumulative effect adjustment on our condensed consolidated financial statements.
Fair Value Measurements	Financial assets and liabilities recorded at fair value in the condensed consolidated financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels, which are directly related to the amount of subjectivity associated with the inputs to the valuation of these assets or liabilities are as follows: Level 1—Observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Financial assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires management to make judgments and considers factors specific to the asset or liability.
Net Income per Share Attributable to Common Stockholders	Basic net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing net income by the weighted-average shares outstanding, including potentially dilutive shares of common equivalents outstanding during the period. The dilutive effect of potential shares of common stock are determined using the treasury stock method. The computation of fully diluted net income per share of Class A common stock assumes the conversion from Class B common stock, while the fully diluted net income per share of Class B common stock does not assume the conversion of those shares.

Acquisitions (Tables)

Acquisitions (Tables)	3 Months Ended
	Apr. 30, 2020
Business Combinations [Abstract]
Schedule of Pro Forma Information from Business Acquisition	Accordingly, these unaudited pro forma results are presented for information purpose only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations (in thousands): Three months ended April 30, 2019 (Unaudited) Pro forma revenues $ 260,351 Pro forma net income $ 67,818 Pro forma net income per share: Basic $ 0.46 Diluted $ 0.43

Short-Term Investments (Tables)

Short-Term Investments (Tables)	3 Months Ended
	Apr. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Schedule of Short-Term Investments	At April 30, 2020 , short-term investments consisted of the following (in thousands): Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available-for-sale securities: Certificates of deposits $ 11,600 $ 38 $ (55 ) $ 11,583 Asset-backed securities 104,406 476 (162 ) 104,720 Commercial paper 37,028 47 (24 ) 37,051 Corporate notes and bonds 270,889 2,283 (410 ) 272,762 Foreign government bonds 4,803 32 (35 ) 4,800 U.S. agency obligations 4,999 3 — 5,002 U.S. treasury securities 222,201 2,080 — 224,281 Total available-for-sale securities $ 655,926 $ 4,959 $ (686 ) $ 660,199 At January 31, 2020 , short-term investments consisted of the following (in thousands): Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available-for-sale securities: Certificates of deposits $ 3,500 $ 3 $ — $ 3,503 Asset-backed securities 100,419 396 (1 ) 100,814 Commercial paper 19,965 5 (1 ) 19,969 Corporate notes and bonds 234,664 1,552 (2 ) 236,214 Foreign government bonds 3,397 10 — 3,407 U.S. treasury securities 245,509 599 — 246,108 Total available-for-sale securities $ 607,454 $ 2,565 $ (4 ) $ 610,015 The following table summarizes the estimated fair value of our short-term investments, designated as available-for-sale and classified by the contractual maturity date of the securities as of the dates shown (in thousands): April 30, January 31, Due in one year or less $ 282,638 $ 247,592 Due in greater than one year 377,561 362,423 Total $ 660,199 $ 610,015
Schedule of Fair Values and Gross Unrealized Loss Position of Available-for-Sale Securities Aggregated by Investment Category	The following table shows the fair values of these available-for-sale securities, some of which have been in an unrealized loss position for more than 12 months, aggregated by investment category as of April 30, 2020 (in thousands): Fair value Gross unrealized losses Certificates of deposits $ 7,945 $ (55 ) Asset-backed securities 19,765 (162 ) Commercial paper 10,609 (24 ) Corporate notes and bonds 56,364 (410 ) Foreign government bonds 3,545 (35 ) The following table shows the fair values of these available-for-sale securities, some of which have been in an unrealized loss position for more than 12 months , aggregated by investment category as of January 31, 2020 (in thousands): Fair value Gross unrealized losses Asset-backed securities $ 2,623 $ (1 ) Commercial paper 5,589 (1 ) Corporate notes and bonds 9,105 (2 )

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	3 Months Ended
	Apr. 30, 2020
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consists of the following as of the dates shown (in thousands): April 30, January 31, Land $ 3,040 $ 3,040 Building 20,984 20,984 Land improvements and building improvements 22,392 22,392 Equipment and computers 10,871 11,066 Furniture and fixtures 12,807 12,849 Leasehold improvements 9,369 9,385 Construction in progress 645 386 80,108 80,102 Less accumulated depreciation (27,222 ) (25,350 ) Total property and equipment, net $ 52,886 $ 54,752

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Apr. 30, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Details of Intangible Assets	The following schedule presents the details of intangible assets as of April 30, 2020 (dollar amounts in thousands): April 30, 2020 Gross carrying amount Accumulated amortization Net Remaining useful life (in years) Existing technology $ 26,380 $ (5,737 ) 20,643 5.5 Customer relationships 111,443 (20,272 ) 91,171 8.7 Trade name/Trademarks 13,900 (1,426 ) 12,474 4.4 Other intangibles 22,947 (17,832 ) 5,115 5.3 $ 174,670 $ (45,267 ) 129,403 The following schedule presents the details of intangible assets as of January 31, 2020 (dollar amounts in thousands): January 31, 2020 Gross carrying amount Accumulated amortization Net Remaining useful life (in years) Existing technology $ 26,380 $ (4,808 ) 21,572 5.8 Customer relationships 111,443 (17,575 ) 93,868 9.0 Trade name/Trademarks 13,900 (720 ) 13,180 4.7 Other intangibles 22,947 (16,966 ) 5,981 5.0 $ 174,670 $ (40,069 ) 134,601
Estimated Amortization Expense	As of April 30, 2020 , the estimated amortization expense for intangible assets, for the next five years and thereafter is as follows (in thousands): Period Estimated amortization expense Remaining for Fiscal 2021 $ 14,396 Fiscal 2022 18,397 Fiscal 2023 18,342 Fiscal 2024 18,160 Fiscal 2025 17,417 Thereafter 42,691 Total $ 129,403

Accrued Expenses (Tables)

Accrued Expenses (Tables)	3 Months Ended
	Apr. 30, 2020
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses consisted of the following as of the dates shown (in thousands): April 30, January 31, Accrued commissions $ 5,868 $ 8,951 Accrued bonus 3,853 4,329 Accrued vacation 4,960 3,921 Payroll tax payable 10,236 7,353 Accrued other compensation and benefits 2,147 1,065 Total accrued compensation and benefits $ 27,064 $ 25,619 Accrued fees payable to salesforce.com 6,059 5,787 Marketing event accruals 3,945 1,132 Taxes payable 3,452 4,914 Accrued third-party professional services subcontractors' fees 1,429 1,338 Other accrued expenses 8,520 8,449 Total accrued expenses and other current liabilities $ 23,405 $ 21,620

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Apr. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis	The following table presents the fair value hierarchy for financial assets measured at fair value on a recurring basis as of April 30, 2020 (in thousands): Level 1 Level 2 Total Assets Cash equivalents: Money market funds $ 307,042 $ — $ 307,042 Certificates of deposits — 150,000 150,000 Commercial paper — 7,496 7,496 Corporate notes and bonds — 2,229 2,229 Short-term investments: Certificates of deposits — 11,583 11,583 Asset-backed securities — 104,720 104,720 Commercial paper — 37,051 37,051 Corporate notes and bonds — 272,761 272,761 Foreign government bonds — 4,800 4,800 U.S. agency obligations — 5,002 5,002 U.S. treasury securities — 224,281 224,281 Foreign currency derivative contracts — 13 13 Total $ 307,042 $ 819,936 $ 1,126,978 Liabilities Foreign currency derivative contracts — 74 74 Total $ — $ 74 $ 74 The following table presents the fair value hierarchy for financial assets measured at fair value on a recurring basis as of January 31, 2020 (in thousands): Level 1 Level 2 Total Assets Cash equivalents: Money market funds $ 24,107 $ — $ 24,107 Commercial paper — 1,616 1,616 Corporate notes and bonds — 2,245 2,245 Short-term investments: Certificates of deposits — 3,503 3,503 Asset-backed securities — 100,815 100,815 Commercial paper — 19,969 19,969 Corporate notes and bonds — 236,214 236,214 Foreign government bonds — 3,407 3,407 U.S. treasury securities — 246,107 246,107 Foreign currency derivative contracts — 75 75 Total $ 24,107 $ 613,951 $ 638,058 Liabilities Foreign currency derivative contracts — 42 42 Total $ — $ 42 $ 42
Summary of Outstanding Balance Sheet Hedges	The fair value of our outstanding derivative instruments is summarized below (in thousands): April 30, January 31, Notional amount of foreign currency derivative contracts $ 10,005 $ 7,304 Fair value of foreign currency derivative contracts 10,065 7,271
Summary Fair Value of Outstanding Derivative Instruments	Details on outstanding balance sheet hedges are presented below as of the date shown below (in thousands): Derivatives not designated as hedging instruments Balance sheet location April 30, January 31, Derivative Assets Foreign currency derivative contracts Prepaid expenses and other current assets $ 13 $ 75 Derivative Liabilities Foreign currency derivative contracts Accrued expenses $ 74 $ 42

Leases (Tables)

Leases (Tables)	3 Months Ended
	Apr. 30, 2020
Leases [Abstract]
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows (in thousands): Three months ended April 30, 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 2,563 $ 1,507 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 306 $ 941
Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount rate): As of As of Operating Leases Lease right-of-use-assets $ 46,923 $ 49,132 Lease liabilities $ 9,114 $ 8,960 Lease liabilities, noncurrent 42,344 44,453 Total operating lease liabilities $ 51,458 $ 53,413 Finance Leases Property and equipment, at cost $ 1,674 $ 1,761 Accumulated depreciation (1,569 ) (1,320 ) Property and equipment, net $ 105 $ 441 Lease liabilities $ 1,013 $ 1,054 Lease liabilities, noncurrent 86 362 Total finance lease liabilities $ 1,099 $ 1,416 Weighted Average Remaining Lease Term Operating leases 7.0 years 7.1 years Finance leases 1.1 years 1.3 years Weighted Average Discount Rate Operating leases 4.2 % 4.3 % Finance leases 4.3 % 4.3 %
Maturities of Lease Liabilities	As of April 30, 2020 , remaining maturities of lease liabilities are as follows (in thousands): Period Operating leases Finance leases Remaining for Fiscal 2021 $ 8,150 $ 778 Fiscal 2022 10,233 346 Fiscal 2023 8,102 — Fiscal 2024 7,352 — Fiscal 2025 5,338 — Thereafter 20,822 — Total lease payments 59,997 1,124 Less imputed interest (8,539 ) (25 ) Total $ 51,458 $ 1,099

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Apr. 30, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of Stock Option Activity	A summary of stock option activity for the three months ended April 30, 2020 is as follows: Number of shares Weighted average exercise price Weighted average remaining contractual term (in years) Aggregate intrinsic value Options outstanding at January 31, 2020 13,448,026 $ 40.64 5.4 $ 1,426,502,005 Options granted 1,264,192 172.55 Options exercised (645,515 ) 15.92 Options forfeited/cancelled (44,252 ) 84.44 Options outstanding at April 30, 2020 14,022,451 $ 53.40 5.6 $ 1,926,725,769 Options vested and exercisable at April 30, 2020 6,759,113 $ 11.99 3.3 $ 1,208,620,921 Options vested and exercisable at April 30, 2020 and 14,022,451 $ 53.40 5.6 $ 1,926,725,769
Summary of Restricted Stock Unit (RSU) Activity	A summary of restricted stock unit (RSU) activity for the three months ended April 30, 2020 is as follows: Unreleased restricted stock units Weighted average grant date fair value Balance at January 31, 2020 1,818,622 $ 95.23 RSUs granted 373,055 171.58 RSUs vested (289,471 ) 75.03 RSUs forfeited/cancelled (29,608 ) 74.92 Balance at April 30, 2020 1,872,598 $ 113.90
Schedule of Weighted-Average Assumptions Used to Estimate Grant Date Fair Value of Options Granted	The following table presents the weighted-average assumptions used to estimate the grant date fair value of options granted during the periods presented: Three months ended 2020 2019 Volatility 39% - 41% 41% Expected term (in years) 6.25 - 7.25 5.75 - 6.35 Risk-free interest rate 0.51% - 1.43% 2.36% - 2.52% Dividend yield —% —%

Net Income per Share (Tables)

Net Income per Share (Tables)	3 Months Ended
	Apr. 30, 2020
Earnings Per Share [Abstract]
Numerators and Denominators of the Basic and Diluted EPS Computations for Common Stock	The numerators and denominators of the basic and diluted EPS computations for our common stock are calculated as follows (in thousands, except per share data): Three months ended April 30, 2020 2019 Class A Class B Class A Class B Basic Numerator Net income, basic $ 77,777 $ 8,793 $ 63,652 $ 9,797 Denominator Weighted average shares used in computing net income per share, basic 134,353 15,188 127,139 19,569 Net income per share, basic $ 0.58 $ 0.58 $ 0.50 $ 0.50 Diluted Numerator Net income, basic $ 77,777 $ 8,793 $ 63,652 $ 9,797 Reallocation as a result of conversion of Class B to Class A common stock: Net income, basic 8,793 — 9,797 — Reallocation of net income to Class B common stock — 4,844 — 4,516 Net income, diluted $ 86,570 $ 13,637 $ 73,449 $ 14,313 Denominator Number of shares used for basic EPS computation 134,353 15,188 127,139 19,569 Conversion of Class B to Class A common stock 15,188 — 19,569 — Effect of potentially dilutive common shares 9,933 9,933 11,202 11,202 Weighted average shares used in computing net income per share, diluted 159,474 25,121 157,910 30,771 Net income per share, diluted $ 0.54 $ 0.54 $ 0.47 $ 0.47
Potential Common Share Equivalents Excluded where the Inclusion would be Anti-dilutive	Potential common share equivalents excluded where the inclusion would be anti-dilutive are as follows: Three months ended 2020 2019 Options and awards to purchase shares not included in the computation of diluted net income per share because their inclusion would be anti-dilutive 2,386,498 376,944

Revenues by Product (Tables)

Revenues by Product (Tables)	3 Months Ended
	Apr. 30, 2020
Revenue from Contract with Customer [Abstract]
Summary of Total Revenues	Total revenues consist of the following (in thousands): Three months ended 2020 2019 Subscription services Veeva Commercial Cloud $ 142,577 $ 105,796 Veeva Vault 127,658 92,319 Total subscription services $ 270,235 $ 198,115 Professional services Veeva Commercial Cloud $ 27,376 $ 17,221 Veeva Vault 39,495 29,416 Total professional services $ 66,871 $ 46,637 Total revenues $ 337,106 $ 244,752

Information about Geographic _2

Information about Geographic Areas (Tables)	3 Months Ended
	Apr. 30, 2020
Segment Reporting [Abstract]
Revenues by Geographic Area	Total revenues by geographic area were as follows for the periods shown below (in thousands): Three months ended April 30, 2020 2019 Revenues by geography North America $ 195,657 $ 132,131 Europe 89,422 70,374 Asia Pacific 42,292 34,368 Rest of world (1) 9,735 7,879 Total revenues $ 337,106 $ 244,752 _________________________________________________________ (1) Middle East, Africa, and Latin America
Long-Lived Assets by Geographic Area	Long-lived assets by geographic area are as follows as of the periods shown below (in thousands): April 30, January 31, 2020 2020 Long-lived assets by geography North America $ 46,536 $ 51,334 Europe and rest of world 1,756 2,077 Asia Pacific 4,594 1,341 Total long-lived assets $ 52,886 $ 54,752

Summary of Business and Signi_3

Summary of Business and Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Summary Of Business And Accounting Policies [Line Items]
Unbilled accounts receivable	$ 37,269	$ 32,817
Professional services and other
Summary Of Business And Accounting Policies [Line Items]
Unbilled accounts receivable	21,000	18,000
Subscription services
Summary Of Business And Accounting Policies [Line Items]
Unbilled accounts receivable	$ 17,000	$ 15,000

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - USD ($) $ in Millions	Nov. 07, 2019	Nov. 01, 2019
Crossix Solutions
Business Acquisition [Line Items]
Percentage of voting interests acquired		100.00%
Consideration transferred		$ 428
Equity retention awards		$ 120
Physicians World
Business Acquisition [Line Items]
Consideration transferred	$ 41
Equity retention awards	$ 15

Acquisitions - Schedule of Pro

Acquisitions - Schedule of Pro Forma Information (Details)	3 Months Ended
	Apr. 30, 2019USD ($)$ / shares
Business Combinations [Abstract]
Pro forma revenues | $	$ 260,351,000
Pro forma net income | $	$ 67,818,000
Pro forma net income per share:
Basic (in dollars per share) | $ / shares	$ 0.46
Diluted (in dollars per share) | $ / shares	$ 0.43

Short-Term Investments - Schedu

Short-Term Investments - Schedule of Short-Term Investments (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	$ 655,926	$ 607,454
Gross unrealized gains	4,959	2,565
Gross unrealized losses	(686)	(4)
Estimated fair value	660,199	610,015
Certificates of deposits
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	11,600	3,500
Gross unrealized gains	38	3
Gross unrealized losses	(55)	0
Estimated fair value	11,583	3,503
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	104,406	100,419
Gross unrealized gains	476	396
Gross unrealized losses	(162)	(1)
Estimated fair value	104,720	100,814
Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	37,028	19,965
Gross unrealized gains	47	5
Gross unrealized losses	(24)	(1)
Estimated fair value	37,051	19,969
Corporate notes and bonds
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	270,889	234,664
Gross unrealized gains	2,283	1,552
Gross unrealized losses	(410)	(2)
Estimated fair value	272,762	236,214
Foreign government bonds
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	4,803	3,397
Gross unrealized gains	32	10
Gross unrealized losses	(35)	0
Estimated fair value	4,800	3,407
U.S. agency obligations
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	4,999
Gross unrealized gains	3
Gross unrealized losses	0
Estimated fair value	5,002
U.S. treasury securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	222,201	245,509
Gross unrealized gains	2,080	599
Gross unrealized losses	0	0
Estimated fair value	$ 224,281	$ 246,108

Short-Term Investments - Summar

Short-Term Investments - Summary of Estimated Fair Value of Short-Term Investments, Designated as Available-for-Sale and Classified by Contractual Maturity (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Due in one year or less	$ 282,638	$ 247,592
Due in greater than one year	377,561	362,423
Total	$ 660,199	$ 610,015

Short-Term Investments - Sche_2

Short-Term Investments - Schedule of Fair Values and Gross Unrealized Loss Position of Available-for-Sale Securities Aggregated by Investment Category (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Certificates of deposits
Schedule of Available-for-sale Securities [Line Items]
Fair value	$ 7,945
Gross unrealized losses	(55)
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Fair value	19,765	$ 2,623
Gross unrealized losses	(162)	(1)
Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Fair value	10,609	5,589
Gross unrealized losses	(24)	(1)
Corporate notes and bonds
Schedule of Available-for-sale Securities [Line Items]
Fair value	56,364	9,105
Gross unrealized losses	(410)	$ (2)
Foreign government bonds
Schedule of Available-for-sale Securities [Line Items]
Fair value	3,545
Gross unrealized losses	$ (35)

Deferred Costs - Additional Inf

Deferred Costs - Additional Information (Detail) - USD ($)	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Jan. 31, 2020
Deferred Costs [Abstract]
Deferred costs	$ 34,176,000		$ 35,585,000
Amortization of deferred costs	4,751,000	$ 4,849,000
Impairment losses recorded in relation to the costs capitalized	$ 0	$ 0

Property and Equipment, Net - C

Property and Equipment, Net - Components of Property and Equipment, Net (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 80,108	$ 80,102
Less accumulated depreciation	(27,222)	(25,350)
Total property and equipment, net	52,886	54,752
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,040	3,040
Building
Property, Plant and Equipment [Line Items]
Property and equipment, gross	20,984	20,984
Land improvements and building improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	22,392	22,392
Equipment and computers
Property, Plant and Equipment [Line Items]
Property and equipment, gross	10,871	11,066
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	12,807	12,849
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	9,369	9,385
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 645	$ 386

Property and Equipment, Net - A

Property and Equipment, Net - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Property, Plant and Equipment [Abstract]
Depreciation	$ 2	$ 2

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Details of Intangible Assets (Detail) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2020	Jan. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 174,670	$ 174,670
Accumulated amortization	(45,267)	(40,069)
Total	129,403	134,601
Existing technology
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	26,380	26,380
Accumulated amortization	(5,737)	(4,808)
Total	$ 20,643	$ 21,572
Remaining useful life (in years)	5 years 6 months	5 years 9 months 18 days
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 111,443	$ 111,443
Accumulated amortization	(20,272)	(17,575)
Total	$ 91,171	$ 93,868
Remaining useful life (in years)	8 years 8 months 12 days	9 years
Trade name/Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 13,900	$ 13,900
Accumulated amortization	(1,426)	(720)
Total	$ 12,474	$ 13,180
Remaining useful life (in years)	4 years 4 months 24 days	4 years 8 months 12 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 22,947	$ 22,947
Accumulated amortization	(17,832)	(16,966)
Total	$ 5,115	$ 5,981
Remaining useful life (in years)	5 years 3 months 18 days	5 years

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Jan. 31, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Goodwill	$ 438,529		$ 438,529
Amortization expense	$ 5,000	$ 2,000

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Estimated Amortization Expense (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Remaining for Fiscal 2021	$ 14,396
Fiscal 2022	18,397
Fiscal 2023	18,342
Fiscal 2024	18,160
Fiscal 2025	17,417
Thereafter	42,691
Total	$ 129,403	$ 134,601

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Accrued Expenses (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Payables and Accruals [Abstract]
Accrued commissions	$ 5,868	$ 8,951
Accrued bonus	3,853	4,329
Accrued vacation	4,960	3,921
Payroll tax payable	10,236	7,353
Accrued other compensation and benefits	2,147	1,065
Total accrued compensation and benefits	27,064	25,619
Accrued fees payable to salesforce.com	6,059	5,787
Marketing event accruals	3,945	1,132
Taxes payable	3,452	4,914
Accrued third-party professional services subcontractors' fees	1,429	1,338
Other accrued expenses	8,520	8,449
Total accrued expenses and other current liabilities	$ 23,405	$ 21,620

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Assets
Short-term investments	$ 660,199	$ 610,015
Certificates of deposits
Assets
Short-term investments	11,583	3,503
Commercial paper
Assets
Short-term investments	37,051	19,969
Corporate notes and bonds
Assets
Short-term investments	272,762	236,214
Asset-backed securities
Assets
Short-term investments	104,720	100,814
Foreign government bonds
Assets
Short-term investments	4,800	3,407
U.S. agency obligations
Assets
Short-term investments	5,002
U.S. treasury securities
Assets
Short-term investments	224,281	246,108
Fair value, measurements recurring
Assets
Total	1,126,978	638,058
Liabilities
Total	74	42
Fair value, measurements recurring | Money market funds
Assets
Cash equivalents:	307,042	24,107
Fair value, measurements recurring | Certificates of deposits
Assets
Cash equivalents:	150,000
Short-term investments	11,583	3,503
Fair value, measurements recurring | Commercial paper
Assets
Cash equivalents:	7,496	1,616
Short-term investments	37,051	19,969
Fair value, measurements recurring | Corporate notes and bonds
Assets
Cash equivalents:	2,229	2,245
Short-term investments	272,761	236,214
Fair value, measurements recurring | Asset-backed securities
Assets
Short-term investments	104,720	100,815
Fair value, measurements recurring | Foreign government bonds
Assets
Short-term investments	4,800	3,407
Fair value, measurements recurring | U.S. agency obligations
Assets
Short-term investments	5,002
Fair value, measurements recurring | U.S. treasury securities
Assets
Short-term investments	224,281	246,107
Fair value, measurements recurring | Foreign currency derivative contracts
Assets
Short-term investments	13	75
Fair value, measurements recurring | Foreign currency derivative contracts
Liabilities
Foreign currency derivative contracts	74	42
Fair value, measurements recurring | Level 1
Assets
Total	307,042	24,107
Liabilities
Total	0	0
Fair value, measurements recurring | Level 1 | Money market funds
Assets
Cash equivalents:	307,042	24,107
Fair value, measurements recurring | Level 1 | Certificates of deposits
Assets
Cash equivalents:	0
Short-term investments	0	0
Fair value, measurements recurring | Level 1 | Commercial paper
Assets
Cash equivalents:	0	0
Short-term investments	0	0
Fair value, measurements recurring | Level 1 | Corporate notes and bonds
Assets
Cash equivalents:	0	0
Short-term investments	0	0
Fair value, measurements recurring | Level 1 | Asset-backed securities
Assets
Short-term investments	0	0
Fair value, measurements recurring | Level 1 | Foreign government bonds
Assets
Short-term investments	0	0
Fair value, measurements recurring | Level 1 | U.S. agency obligations
Assets
Short-term investments	0
Fair value, measurements recurring | Level 1 | U.S. treasury securities
Assets
Short-term investments	0	0
Fair value, measurements recurring | Level 1 | Foreign currency derivative contracts
Assets
Short-term investments	0	0
Fair value, measurements recurring | Level 1 | Foreign currency derivative contracts
Liabilities
Foreign currency derivative contracts	0	0
Fair value, measurements recurring | Level 2
Assets
Total	819,936	613,951
Liabilities
Total	74	42
Fair value, measurements recurring | Level 2 | Money market funds
Assets
Cash equivalents:	0	0
Fair value, measurements recurring | Level 2 | Certificates of deposits
Assets
Cash equivalents:	150,000
Short-term investments	11,583	3,503
Fair value, measurements recurring | Level 2 | Commercial paper
Assets
Cash equivalents:	7,496	1,616
Short-term investments	37,051	19,969
Fair value, measurements recurring | Level 2 | Corporate notes and bonds
Assets
Cash equivalents:	2,229	2,245
Short-term investments	272,761	236,214
Fair value, measurements recurring | Level 2 | Asset-backed securities
Assets
Short-term investments	104,720	100,815
Fair value, measurements recurring | Level 2 | Foreign government bonds
Assets
Short-term investments	4,800	3,407
Fair value, measurements recurring | Level 2 | U.S. agency obligations
Assets
Short-term investments	5,002
Fair value, measurements recurring | Level 2 | U.S. treasury securities
Assets
Short-term investments	224,281	246,107
Fair value, measurements recurring | Level 2 | Foreign currency derivative contracts
Assets
Short-term investments	13	75
Fair value, measurements recurring | Level 2 | Foreign currency derivative contracts
Liabilities
Foreign currency derivative contracts	$ 74	$ 42

Fair Value Measurements - Summa

Fair Value Measurements - Summary Fair Value of Outstanding Derivative Instruments (Detail) - Foreign currency derivative contracts - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Derivatives, Fair Value [Line Items]
Notional amount of foreign currency derivative contracts	$ 10,005	$ 7,304
Fair value of foreign currency derivative contracts	$ 10,065	$ 7,271

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Outstanding Balance Sheet Hedges (Detail) - Foreign currency derivative contracts - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative Assets	$ 13	$ 75
Accrued expenses
Derivatives, Fair Value [Line Items]
Derivative Liabilities	$ 74	$ 42

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Income Tax Disclosure [Abstract]
Effective tax rates	4.80%	5.00%
Excess tax benefits recognized	$ 19,615	$ 13,552

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations - Additional Information (Detail) - Subscription services - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Revenue From Contracts With Customers [Line Items]
Recognition of deferred revenue	$ 192	$ 146
Revenue expected to be recognized from remaining performance obligations	$ 913

Deferred Revenue and Perfomance

Deferred Revenue and Perfomance Obligations - Performance Obligation Duration (Details) - Subscription services - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-05-01	Apr. 30, 2020
Revenue From Contracts With Customers [Line Items]
Revenue, remaining performance obligation, percentage	79.00%
Revenue, remaining performance obligation, recognition period	12 months

Leases - Additional Information

Leases - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Leases [Line Items]
Operating lease expense	$ 3	$ 2
Additional operating leasess, primarily for office leases, that have not yet commenced	$ 3
Maximum
Leases [Line Items]
Operating leases, options to extend leases term	9 years
Finance leases, options to extend leases term	9 years
Additional operating leases that have not yet commenced, lease terms	5 years
Minimum
Leases [Line Items]
Additional operating leases that have not yet commenced, lease terms	3 years

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information Related to Leases (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 2,563	$ 1,507
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 306	$ 941

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information Related to Leases (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Operating Leases
Lease right-of-use-assets	$ 46,923	$ 49,132
Lease liabilities	9,114	8,960
Lease liabilities, noncurrent	42,344	44,453
Total operating lease liabilities	51,458	53,413
Finance Leases
Property and equipment, at cost	1,674	1,761
Accumulated depreciation	(1,569)	(1,320)
Property and equipment, net	105	441
Lease liabilities	1,013	1,054
Lease liabilities, noncurrent	86	362
Total finance lease liabilities	$ 1,099	$ 1,416
Weighted Average Remaining Lease Term
Operating leases	7 years	7 years 1 month 6 days
Finance leases	1 year 1 month 6 days	1 year 3 months 18 days
Weighted Average Discount Rate
Operating leases	4.20%	4.30%
Finance leases	4.30%	4.30%

Leases- Maturities of lease lia

Leases- Maturities of lease liabilities (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Operating leases
Remaining for Fiscal 2021	$ 8,150
Fiscal 2022	10,233
Fiscal 2023	8,102
Fiscal 2024	7,352
Fiscal 2025	5,338
Thereafter	20,822
Total lease payments	59,997
Less imputed interest	(8,539)
Total	51,458	$ 53,413
Finance leases
Remaining for Fiscal 2021	778
Fiscal 2022	346
Fiscal 2023	0
Fiscal 2024	0
Fiscal 2025	0
Thereafter	0
Total lease payments	1,124
Less imputed interest	(25)
Total	$ 1,099	$ 1,416

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) $ / shares in Units, $ in Millions	3 Months Ended
	Apr. 30, 2020USD ($)$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to unvested stock options granted	$ 265
Intrinsic value of options exercised	$ 90
2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of options granted (in usd per share) | $ / shares	$ 68.56
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period of unvested stock (in years)	2 years 6 months
Unrecognized compensation cost related to unvested RSUs	$ 196
Total intrinsic value, vested	$ 43
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period of unvested stock (in years)	3 years 9 months 18 days

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Stock Option Activity (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Apr. 30, 2020	Jan. 31, 2020
Number of shares
Options outstanding, Beginning balance (in shares)	13,448,026
Options granted (in shares)	1,264,192
Options exercised (in shares)	(645,515)
Options forfeited/cancelled (in shares)	(44,252)
Options outstanding, Ending balance (in shares)	14,022,451	13,448,026
Options vested and exercisable (in shares)	6,759,113
Options vested and exercisable and expected to vest thereafter (in shares)	14,022,451
Weighted average exercise price
Options outstanding, Beginning balance (in usd per share)	$ 40.64
Options granted (in usd per share)	172.55
Options exercised (in usd per share)	15.92
Options forfeited/cancelled (in usd per share)	84.44
Options outstanding, Ending balance (in usd per share)	53.40	$ 40.64
Options vested and exercisable (in usd per share)	11.99
Options vested and exercisable and expected to vest thereafter (in usd per share)	$ 53.40
Weighted average remaining contractual term (in years), Options outstanding	5 years 7 months 6 days	5 years 4 months 24 days
Weighted average remaining contractual term (in years), Options vested and exercisable	3 years 3 months 18 days
Weighted average remaining contractual term (in years), Options vested and exercisable and expected to vest thereafter	5 years 7 months 6 days
Aggregate intrinsic value
Options outstanding	$ 1,926,725,769	$ 1,426,502,005
Options vested and exercisable	1,208,620,921
Options vested and exercisable and expected to vest thereafter	$ 1,926,725,769

Stockholders' Equity - Summar_2

Stockholders' Equity - Summary of Restricted Stock Unit (RSU) Activity (Detail) - Restricted Stock Units (RSUs)	3 Months Ended
	Apr. 30, 2020$ / sharesshares
Unreleased restricted stock units
Beginning Balance (in shares) | shares	1,818,622
RSUs granted (in shares) | shares	373,055
RSUs vested (in shares) | shares	(289,471)
RSUs forfeited/cancelled (in shares) | shares	(29,608)
Ending Balance (in shares) | shares	1,872,598
Weighted average grant date fair value
Beginning Balance (in usd per share) | $ / shares	$ 95.23
RSUs granted (in usd per share) | $ / shares	171.58
RSUs vested (in usd per share) | $ / shares	75.03
RSUs forfeited/cancelled (in usd per share) | $ / shares	74.92
Ending Balance (in usd per share) | $ / shares	$ 113.90

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Weighted-Average Assumptions Used to Estimate Grant Date Fair Value of Options Granted (Detail) - Stock Options	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility		41.00%
Risk-free interest rate, Minimum	0.51%	2.36%
Risk-free interest rate, Maximum	1.43%	2.52%
Dividend yield	0.00%	0.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	39.00%
Expected term (in years)	6 years 3 months	5 years 9 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	41.00%
Expected term (in years)	7 years 3 months	6 years 4 months 6 days

Net Income per Share - Numerato

Net Income per Share - Numerators and Denominators of the Basic and Diluted EPS Computations for Common Stock (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Weighted average shares used in computing net income per share, basic	149,541	146,708
Net income per share attributable to common stockholders, basic (in usd per share)	$ 0.58	$ 0.50
Reallocation as a result of conversion of Class B to Class A common stock:
Weighted average shares used in computing net income per share, diluted	159,474	157,910
Net income per share attributable to common stockholders, diluted (in usd per share)	$ 0.54	$ 0.47
Class A common stock
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Net income, basic	$ 77,777	$ 63,652
Weighted average shares used in computing net income per share, basic	134,353	127,139
Net income per share attributable to common stockholders, basic (in usd per share)	$ 0.58	$ 0.50
Net income, basic	$ 77,777	$ 63,652
Reallocation as a result of conversion of Class B to Class A common stock:
Net income, basic	8,793	9,797
Reallocation of net income to Class B common stock	0
Net income, diluted	$ 86,570	$ 73,449
Conversion of Class B to Class A common stock	15,188	19,569
Effect of potentially dilutive common shares	9,933	11,202
Weighted average shares used in computing net income per share, diluted	159,474	157,910
Net income per share attributable to common stockholders, diluted (in usd per share)	$ 0.54	$ 0.47
Class B common stock
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Net income, basic	$ 8,793	$ 9,797
Weighted average shares used in computing net income per share, basic	15,188	19,569
Net income per share attributable to common stockholders, basic (in usd per share)	$ 0.58	$ 0.50
Net income, basic	$ 8,793	$ 9,797
Reallocation as a result of conversion of Class B to Class A common stock:
Net income, basic	0	0
Reallocation of net income to Class B common stock	4,844	4,516
Net income, diluted	$ 13,637	$ 14,313
Conversion of Class B to Class A common stock	0	0
Effect of potentially dilutive common shares	9,933	11,202
Weighted average shares used in computing net income per share, diluted	25,121	30,771
Net income per share attributable to common stockholders, diluted (in usd per share)	$ 0.54	$ 0.47

Net Income per Share - Potentia

Net Income per Share - Potential Common Share Equivalents Excluded where the Inclusion would be Anti-dilutive (Detail) - shares	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Earnings Per Share [Abstract]
Options and awards to purchase shares not included in the computation of diluted net income per share because their inclusion would be anti-dilutive	2,386,498	376,944

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail)	Mar. 13, 2017USD ($)	Jan. 26, 2017Employee	Apr. 30, 2020USD ($)
Value-Added Reseller Agreement
Long-term Purchase Commitment [Line Items]
Minimum order commitment			$ 500,000,000
Amount of first minimum order commitment met			250,000,000
Minimum fee commitment obligation			120,000,000
IQVIA Litigation Matter | Minimum
Long-term Purchase Commitment [Line Items]
Monetary damages	$ 200,000,000
Medidata Litigation Matter
Long-term Purchase Commitment [Line Items]
Number of former employees | Employee		5
Present to September 1st, 2025 | Value-Added Reseller Agreement
Long-term Purchase Commitment [Line Items]
Minimum order commitment			500,000,000
March 1st 2014 to September 1st, 2020 | Value-Added Reseller Agreement
Long-term Purchase Commitment [Line Items]
Minimum order commitment			$ 250,000,000

Revenues by Product - Summary o

Revenues by Product - Summary of Total Revenues (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Disaggregation of Revenue [Line Items]
Total revenues	$ 337,106	$ 244,752
Veeva Commercial Cloud
Disaggregation of Revenue [Line Items]
Total revenues	142,577	105,796
Veeva Vault
Disaggregation of Revenue [Line Items]
Total revenues	127,658	92,319
Total subscription services
Disaggregation of Revenue [Line Items]
Total revenues	270,235	198,115
Veeva Commercial Cloud
Disaggregation of Revenue [Line Items]
Total revenues	27,376	17,221
Veeva Vault
Disaggregation of Revenue [Line Items]
Total revenues	39,495	29,416
Total professional services
Disaggregation of Revenue [Line Items]
Total revenues	$ 66,871	$ 46,637

Information about Geographic _3

Information about Geographic Areas - Revenues by Geographic Area (Detail) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Revenues by geography
Total revenues	$ 337,106	$ 244,752
North America
Revenues by geography
Total revenues	195,657	132,131
Europe
Revenues by geography
Total revenues	89,422	70,374
Asia Pacific
Revenues by geography
Total revenues	42,292	34,368
Rest of world
Revenues by geography
Total revenues	$ 9,735	$ 7,879

Information about Geographic _4

Information about Geographic Areas - Long-Lived Assets by Geographic Area (Detail) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Long-lived assets by geography
Total long-lived assets	$ 52,886	$ 54,752
North America
Long-lived assets by geography
Total long-lived assets	46,536	51,334
Europe and rest of world
Long-lived assets by geography
Total long-lived assets	1,756	2,077
Asia Pacific
Long-lived assets by geography
Total long-lived assets	$ 4,594	$ 1,341

Uncategorized Items - veev-2020

Label	Element	Value
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	$ 1,207,000
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	$ 3,065,000